1 ent had treatment interrupted for 1 dose for mastoiditis.

2  infection, osteomyelitis, endocarditis, and mastoiditis.

3 rates steadily increased during that period, mastoiditis and ventilating tube insertion rates decreas

4  including local cellulitis, perichondritis, mastoiditis, and intracranial complications, were report

5                                              Mastoiditis developed in one child who received placebo.

6 from cultures taken from children with OM or mastoiditis for clinical indications have decreased foll

7 phalitis, intussusception, Kawasaki disease, mastoiditis, myocarditis, necrotizing fasciitis, nontrau

8 ), pneumonia (n = 4), abscess/wound (n = 3), mastoiditis (n = 2), cellulitis (n = 2), peritonitis (n

9                                              Mastoiditis rates substantially decreased (from 61 per 1

10 mmon cause of otitis media (OM) in children; mastoiditis remains an important complication of OM.

11                         We present a case of mastoiditis where Gram stain, culture, and molecular dia